Global Health IPO Details: Price, Dates & Financials
The Global Health IPO GMP strength score is 6.9 out of 10, which the dashboard rates as Good. The Global Health IPO valuation is tagged Moderate. The Global Health IPO QIB category is reserved for 50% of the offer. The Global Health IPO NII/HNI category is reserved for 15% of the offer. The Global Health IPO Retail (RII) category is reserved for 35% of the offer. Live subscription numbers for the Global Health IPO are not yet available, and amounts are calculated at the upper price band of ₹336.
IPO Analytics Dashboard
LIVE
Global Health IPO GMP Insights
👤
Retail Demand
Good
💼
HNI Interest
Good
🏦
QIB Demand
Strong
📊
Valuation
Moderate
Global Health IPO GMP Strength Score
7 / 10
Good
0–3 Weak3–6 Moderate6–8 Good8–10 Strong
Global Health IPO Category-wise Subscription
Shares offered, bid & amount
Category
Sub (x)
Offered
Bid For
🏦
QIB
—
32,820,975 (50%)
—
💼
NII / HNI
—
9,846,293 (15%)
—
👤
Retail (RII)
—
22,974,684 (35%)
—
Σ
Total
—
65,641,952 (100%)
—
* Amount calculated at upper price band (₹336) ·
** Total includes all investor categories
Subscription Overview
Share allocation by investor category
🏦
QIB ?
32,820,975 (50%)
50%
💼
NII / HNI ?
9,846,293 (15%)
15%
👤
Retail (RII) ?
22,974,684 (35%)
35%
Total Shares Offered
65,641,952 (100%)
Global Health IPO Application Sizing
Minimum investment by category
👤
Retail Investors ?
Min. Lots
1
Shares / Lot
44
Min. Investment
₹14,784
💼
HNI Investors ?
Min. Lots
14
Min. Shares
616
Min. Investment
₹206,976
🏛️
bHNI (>₹10L) ?
Min. Lots
68
Min. Shares
2,992
Min. Investment
₹1,005,312
Global Health IPO Valuation — EPS & P/E
Pre & post-issue metrics
Pre-Issue P/E ?
38 x
Global Health IPO Timeline & Key Dates
1
💳
Initiation of Refund
14 Nov 2022
2
📂
Credit of Shares to Demat
15 Nov 2022
3
🔒
Lock-in Period (30%)
December 11, 2022
4
🔒
Lock-in Period (50%)
February 9, 2023
Investor Interpretation
Retail allocation is good at 35% of the total offering.
HNI/NII demand is good at 15%.
Institutional (QIB) interest is strong at 50%.
The IPO P/E of 38x reflects a moderate valuation relative to typical market ranges.
This IPO shows moderate investor interest. Review financial details and
compare valuation with industry peers before investing.
Subscription data for Global Health IPO is not available right now. Numbers are updated here during the bidding window.
In Global Health IPO, retail investors can apply for a minimum of 1 lot(s) (₹₹14,784); HNI/sNII minimum 14 lots (₹₹206,976); bNII minimum 68 lots (₹₹1,005,312).
Global Health IPO valuation — pre-issue P/E 38.36.
30% lock-in period ends: December 11, 2022. 50% lock-in period ends: February 9, 2023.
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.
The NII category covers investors applying for shares outside the retail investor category, while HNI commonly refers to high-value investors within the NII category. Understanding the Global Health IPO's NII and HNI subscription levels helps investors assess demand for the Global Health IPO and overall investor interest.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
